Literature DB >> 6272133

Loperamide reduces the intestinal secretion but not the mucosal cAMP accumulation induced by choleratoxin.

U M Farack, U Kautz, K Loeschke.   

Abstract

The effect of loperamide on net fluid transport and epithelial cAMP accumulation was tested in choleratoxin-exposed ligated colon loops of the rat in vivo. Purified choleratoxin (50 micrograms/ml saline, for 5 h) induced net secretion and doubled cAMP levels in comparison with saline-treated controls. Loperamide (4 mg/kg intragastrically) reduced this secretion by 75%, without diminishing cAMP accumulation; it had no effect on basal fluid transport or cAMP. The data suggest that the opiate analogue interferes with the secretory process at a point beyond the cAMP increase caused by activation of adenylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6272133     DOI: 10.1007/bf00500077

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  17 in total

1.  Loperamide inhibits cholera-toxin-induced small-intestinal secretion.

Authors:  B Sandhu; J H Tripp; D C Candy; J T Harries
Journal:  Lancet       Date:  1979-09-29       Impact factor: 79.321

2.  An improved protein binding assay for cyclic AMP.

Authors:  C O Brostrom; C Kon
Journal:  Anal Biochem       Date:  1974-04       Impact factor: 3.365

3.  Stimulation of intestinal adenyl cyclase by cholera toxin.

Authors:  G W Sharp; S Hynie
Journal:  Nature       Date:  1971-01-22       Impact factor: 49.962

4.  Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 3: in vitro studies on the peristaltic reflex and other experiments on isolated tissues.

Authors:  J M Van Nueten; P A Janssen; J Fontaine
Journal:  Arzneimittelforschung       Date:  1974-10

5.  [Effects of loperamide on the motility of the isolated intestine in guinea pigs, rats and dogs (author's transl)].

Authors:  S Nakayama; T Yamasato; M Mizutani
Journal:  Nihon Heikatsukin Gakkai Zasshi       Date:  1977-06

6.  Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prostaglandins.

Authors:  D V Kimberg; M Field; J Johnson; A Henderson; E Gershon
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808

7.  The effect of loperamide on prostaglandin induced diarrhoea in rat and man.

Authors:  S M Karim; P G Adaikan
Journal:  Prostaglandins       Date:  1977-02

8.  Elevated concentration of adenosine 3':5'-cyclic monophosphate in intestinal mucosa after treatment with cholera toxin.

Authors:  D E Schafer; W D Lust; B Sircar; N D Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1970-10       Impact factor: 11.205

9.  Somatostatin inhibits fluid secretion in the rat jejunum.

Authors:  K Dharmsathaphorn; R S Sherwin; J W Dobbins
Journal:  Gastroenterology       Date:  1980-06       Impact factor: 22.682

10.  Comparative study of the effect of cholera toxin and sodium deoxycholate on the paracellular permeability and on net fluid and electrolyte transfer in the rat colon.

Authors:  K J Goerg; M Gross; G Nell; W Rummel; L Schulz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-05       Impact factor: 3.000

View more
  17 in total

1.  Effects of the prodrug loperamide oxide, loperamide, and placebo on jejunal motor activity.

Authors:  G Stacher; H Steinringer; C Schneider; G V Vacariu-Granser; F Castiglione; G Gaupmann; U Weber; G Stacher-Janotta
Journal:  Dig Dis Sci       Date:  1992-02       Impact factor: 3.199

Review 2.  Pathogenesis and pharmacology of diarrhea.

Authors:  L Ooms; A Degryse
Journal:  Vet Res Commun       Date:  1986-09       Impact factor: 2.459

3.  Nufenoxole, a new antidiarrhoeal agent, inhibits fluid secretion in the human jejunum.

Authors:  K J Moriarty; D D Rolston; M J Kelly; M Shield; M L Clark
Journal:  Gut       Date:  1985-01       Impact factor: 23.059

4.  Secretagogue-induced changes in membrane calcium permeability in chicken and chinchilla ileal mucosa. Selective inhibition by loperamide.

Authors:  E B Chang; D R Brown; N S Wang; M Field
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

5.  Cholera and severe toxigenic diarrhoeas.

Authors:  D R Nalin
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

Review 6.  Racecadotril versus loperamide: antidiarrheal research revisited.

Authors:  S Huighebaert; F Awouters; G N J Tytgat
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

7.  Alpha 2-adrenoceptors inhibit the cholera-toxin-induced intestinal fluid accumulation.

Authors:  T Nakaki; T Nakadate; S Yamamoto; R Kato
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

8.  Inhibition by loperamide of deoxycholic acid induced intestinal secretion.

Authors:  U M Farack; K Loeschke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-03       Impact factor: 3.000

9.  Calcium transport affinity, ion competition and cholera toxin effects on cytosolic Ca concentration.

Authors:  D D Maenz; S E Gabriel; G W Forsyth
Journal:  J Membr Biol       Date:  1987       Impact factor: 1.843

10.  Local inhibition of myoelectrical activity of human colon by loperamide.

Authors:  I Altaparmakov; M Wienbeck
Journal:  Dig Dis Sci       Date:  1984-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.